Susan Burchill

7PUBLICATIONS
64CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyMolecular targetsHaematological tumoursMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 13, 2026
Characterisation of Bespoke Patient-Derived In Vitro Models of Ewing Sarcoma.

Elizabeth A Roundhill, Elton J R Vasconcelos, John Davies

|Oct 29, 2025
Oncolytic Maraba Virus MG1 Mediates Direct and Natural Killer Cell-Dependent Lysis of Ewing Sarcoma.

Tyler Barr, Victoria A Jennings, Elizabeth A Roundhill

|Sep 05, 2025
Advancing Preclinical Biology for Ewing Sarcoma: An International Effort.

Filemon S Dela Cruz, Elizabeth A Stewart, Didier Surdez

|Jan 08, 2024
Bevacizumab, Irinotecan, or Topotecan Added to Temozolomide for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON-Neuroblastoma Trial.

Lucas Moreno, Rebekah Weston, Cormac Owens

|Feb 22, 2022
Flow cytometry of bone marrow aspirates from neuroblastoma patients is a highly sensitive technique for quantification of low-level neuroblastoma.

Neha Jain, Shaista Sattar, Sarah Inglott

|Aug 17, 2021
RNA sequencing and functional studies of patient-derived cells reveal that neurexin-1 and regulators of this pathway are associated with poor outcomes in Ewing sarcoma.

Elizabeth Ann Roundhill, Mariona Chicon-Bosch, Lee Jeys

Pageof 2

Frequent Collaborators

3 joint publications

Elizabeth A Roundhill

2 joint publications

Jessica D Daley

2 joint publications

Shireen S Ganapathi

2 joint publications

Alice Soragni